A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
about
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.Quantifying extracellular matrix turnover in human lung scaffold cultures.Chemical Shifts of the Carbohydrate Binding Domain of Galectin-3 from Magic Angle Spinning NMR and Hybrid Quantum Mechanics/Molecular Mechanics Calculations.Galectins as Molecular Targets for Therapeutic Intervention.
P2860
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@ast
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@en
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@nl
type
label
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@ast
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@en
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@nl
prefLabel
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@ast
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@en
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@nl
P2093
P50
P1476
A Selective Galactose-Coumarin ...... in a Pulmonary Fibrosis Model
@en
P2093
Alison MacKinnon
Balaram Mukhopadhyay
Hans Schambye
Santanu Mandal
Tariq Sethi
Vishal K Rajput
P304
P356
10.1021/ACS.JMEDCHEM.6B00957
P407
P577
2016-09-08T00:00:00Z